A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804
Status:
Completed
Trial end date:
2020-11-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to select a suitable dose of BPS804 by measuring the
strength/quality of bone using a special type of CT scanner. Participants will be treated for
12 months and followed up for a further 12 months.